X0306 4/A 2020-02-13 2020-02-18 false 0001603756 Axonics Modulation Technologies, Inc. AXNX 0001756438 Dearen Danny L. 26 TECHNOLOGY DRIVE IRVINE CA 92618 false true false false See Remarks Common Stock 2020-02-13 4 M false 20103.00 0.00 A 76594.00 D Common Stock 2020-02-13 4 S false 103.00 34.00 D 76491.00 D Common Stock 2020-02-18 4 S false 20000.00 34.25 D 56491.00 D Stock Option (Right to Buy) 0.98 2020-02-13 4 M false 20103.00 0.00 D 2026-01-15 Common Stock 20103.00 97278.00 D The reporting person's original Form 4 for this transaction reported that the shares sold by the reporting person where already owned by the reporting person prior to the sale transaction. The shares sold by the reporting person were actually acquired by the reporting person pursuant to the exercise of stock options immediately prior to the sale transaction as reported in Table I and Table II in the amended Form 4. This sale was pursuant to a 10b5-1 plan adopted by the reporting person on October 10th, 2019. This transaction was executed in multiple trades at prices ranging from $34.00 to $34.43. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. The shares subject to the option vest over a period of four years. 34,346 of the shares subject to the option vested on January 15, 2016 and the remainder vest at a rate of 1/36th per month commencing on January 15, 2017 provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. The option is subject to an early exercise provision and is immediately exercisable. President, Chief Financial Officer /s/ Danny L. Dearen 2020-05-14